EMCDDA Home
  • EN
Search

Figure GPS-21. Trends in last 12 months prevalence of ecstasy use among young adults (aged 15–34)

Part (i) All countries

 
 
YearBulgariaCzech RepublicDenmarkGermanyEstoniaIrelandGreeceSpainFrance ItalyCyprusLatviaLithuaniaHungaryNetherlandsAustriaPolandPortugalRomaniaSlovakiaFinland SwedenUK (E&W)Norway
Related links:
1993
19942.1
19952.12.5
19963.5
19971.91.6
19981.00.31.82.00.40.03.1
19991.70.41.2
20001.21.60.52.60.80.44.1
20013.80.31.42.30.84.5
20025.90.80.52.01.34.3
20031.93.72.32.90.71.92.64.1
20047.70.40.91.73.11.53.71.2
20051.10.91.00.72.73.4
20061.22.51.30.72.71.33.9
20071.42.42.71.00.90.23.1
20081.67.71.12.32.31.01.91.00.23.9
20092.811.813.20.6
20101.60.80.43.10.40.91.13
20112.50.91.40.82.8
Statistical bulletin 2006: Figure GPS-8
Statistical bulletin 2007: Figure GPS-21
Statistical bulletin 2008: Figure GPS-21 part (i)
Statistical bulletin 2009: Figure GPS-21 part (i)
Statistical bulletin 2010: Figure GPS-21 part (i)
Statistical bulletin 2011: Figure GPS-21 part (i)
Statistical bulletin 2012: Figure GPS-21 part (i)
See also Table GPS-0
Sample sizes (respondents) for the 15 to 34 age group for each country and year are presented in Table GPS-8 part ii
See also 'General notes for interpreting data' on the Explanatory notes and help page

Notes:

Data taken from national surveys available in each country. Figures and methodology for each survey can be consulted in Table GPS-8 part ii.

For young adults, the EMCDDA uses the range 15 to 34 years (Denmark and the UK from 16 years, Germany, Estonia (1998) and Hungary from 18 years).

The most recent general population survey reported by the Netherlands display a wide variation in results compared with 2005 which may reflect methodological differences.

The most recent general population survey reported by Italy display a wide variation in results compared with the previous surveys which may reflect methodological differences. The data is provided for information, but given the lack of comparability between surveys should be treated with caution.

Sources:

Reitox national reports 2012, taken from population surveys, reports or scientific articles.

Year 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
Bulgaria                         1.1   1.4 1.6      
Czech Republic                   5.9   7.7       7.7 2.8 1.6 2.5
Denmark               1.2         0.9     1.1   0.8  
Germany     2.1   1.9     1.6     1.9     1.2     1    
Estonia           1.0         3.7         2.3      
Ireland                     2.3       2.4       0.9
Greece           0.3           0.4              
Spain     2.5   1.6   1.7   3.8   2.9     2.5   2.3 1.8   1.4
France              0.4 0.5   0.8     1.0         0.4  
Italy                 0.3   0.7   0.7     1.0      
Cyprus                           1.3     1    
Latvia                     1.9       2.7       0.8
Lithuania                       0.9       1.9      
Hungary                 1.4   2.6       1.0        
Netherlands           1.8     2.3       2.7            
Austria                       1.7       1.0      
Poland                   0.5       0.7       3.1  
Portugal                 0.8           0.9        
Romania                             0.2     0.4  
Slovakia           2.0   2.6   2.0   3.1   2.7       0.9  
Finland            0.4   0.8   1.3   1.5   1.3       1.1  
Sweden           0.0   0.4               0.2      
UK (E&W)   2.1   3.5   3.1   4.1 4.5 4.3 4.1 3.7 3.4 3.9 3.1 3.9 3.2 3 2.8
Norway             1.2         1.2         0.6    

gpsfig21a

 

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Tuesday, 07 May 2013